The article makes the overview about new bone-seeking therapeutic radiopharmaceuticals, as are 117mSn (+4)-DTPA, 188Re-HEDP and 90Y-EDTMP. These radiopharmaceuticals haven''t been certificated in Czech Republic yet and are indicated for treatment of painful bone metastases in the breast and prostate cancer.